India Medtronic Private Limited has recently announced the launch of its new Azure pacemaker that can communicate directly with smartphones and tablets of the patient.
The latest addition to Medtronic’s Cardiac Rhythm & Heart Failure portfolio in India, Azure, is designed to detect and reduce the likelihood of atrial fibrillation.
The pacemaker features BlueSync technology which enables automatic, secure wireless communication via Bluetooth Low Energy and remote monitoring via the Medtronic CareLink Network, providing more timely alerts of clinically relevant patient events that can be reviewed by a clinician at any time.
Security controls implemented and validated on BlueSync enabled devices to include access restrictions to protect the integrity of device functionality and end-to-end encryption to protect patient data, said the company. The device offers improved longevity (up to 13.7 years), so patients potentially need fewer replacements and allow them to have magnetic resonance imaging (MRI) scans in either 1.5 or 3 Tesla (T) machines.
“The pacemaker communicates directly and securely with the MyCareLink Heart mobile app – an important advancement in the ongoing quest to constantly monitor patient condition remotely,” said Madan Krishnan, vice president, India Medtronic, and Minimally Invasive Therapies Group APAC.
Remote monitoring of heart conditions allows patients to receive expert medical advice from their physician while at home or travelling instead of making multiple trips to the hospital, he added.